| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adult-onset Still's disease after mRNA COVID-19 vaccine
|
Magliulo, Daniel
|
|
|
3 |
10 |
p. e680-e682
|
article
|
| 2 |
Adult-onset Still's disease following COVID-19 vaccination
|
Leone, Flavia
|
|
|
3 |
10 |
p. e678-e680
|
article
|
| 3 |
A role for interleukin-1 receptor antagonism in severe COVID-19?
|
Tattersall, Rachel S
|
|
|
3 |
10 |
p. e672-e673
|
article
|
| 4 |
Arthritis and fertility: time to think about men
|
The Lancet Rheumatology,
|
|
|
3 |
10 |
p. e671
|
article
|
| 5 |
Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study
|
Shin, Youn Ho
|
|
|
3 |
10 |
p. e698-e706
|
article
|
| 6 |
Correction to Lancet Rheumatol 2019; 1: e145–53
|
|
|
|
3 |
10 |
p. e687
|
article
|
| 7 |
COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
|
Fagni, Filippo
|
|
|
3 |
10 |
p. e724-e736
|
article
|
| 8 |
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
|
Kyriazopoulou, Evdoxia
|
|
|
3 |
10 |
p. e690-e697
|
article
|
| 9 |
Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases
|
Antonelli, Alessandro
|
|
|
3 |
10 |
p. e675-e676
|
article
|
| 10 |
Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies
|
Mease, Philip J
|
|
|
3 |
10 |
p. e715-e723
|
article
|
| 11 |
Expanding role of biomarkers in characterising hyperinflammatory syndromes
|
Rocco, Joseph M
|
|
|
3 |
10 |
p. e684-e685
|
article
|
| 12 |
Expanding role of biomarkers in characterising hyperinflammatory syndromes – Authors' reply
|
Kessel, Christoph
|
|
|
3 |
10 |
p. e685-e686
|
article
|
| 13 |
FDA approval for anifrolumab in patients with lupus
|
Burki, Talha Khan
|
|
|
3 |
10 |
p. e689
|
article
|
| 14 |
First data on COVID-19 morbidity and mortality in patients with rheumatic disease from South Korea
|
Schreiber, Karen
|
|
|
3 |
10 |
p. e673-e675
|
article
|
| 15 |
How should we define disease and outcomes in axial psoriatic arthritis?
|
Coates, Laura C
|
|
|
3 |
10 |
p. e677-e678
|
article
|
| 16 |
Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases
|
Hausmann, Jonathan S
|
|
|
3 |
10 |
p. e707-e714
|
article
|
| 17 |
Pausing drugs and spacing vaccines: an open question
|
Rodziewicz, Mia
|
|
|
3 |
10 |
p. e683
|
article
|
| 18 |
Pausing drugs and spacing vaccines: an open question – Authors' reply
|
Rubbert-Roth, Andrea
|
|
|
3 |
10 |
p. e683-e684
|
article
|
| 19 |
Research in Brief
|
Thorley, Jennifer
|
|
|
3 |
10 |
p. e688
|
article
|
| 20 |
Socioeconomic deprivation worsens rheumatoid arthritis
|
The Lancet Rheumatology,
|
|
|
3 |
10 |
p. e671
|
article
|
Journal description